PLAT and Stroke: Although tPA is widely available in the United States, only 10–20% of stroke patients receive such treatment (21, 22), primarily because patients may present with mild deficits, are beyond 4.5 h after onset, have conditions or concomitant medications that increase bleeding risk, or for other reasons.